Radiation induced lung injury: Prediction, assessment and management

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 7, 2015, Pages 2613-2617

  Giridhar, Prashanth ^a   Mallick, Supriya ^a   Rath, Goura Kishore ^a   Julka, Pramod Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fibrosis; Lung cancer; Pneumonitis; Radiation

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTOXIFYLLINE; PREDNISOLONE; RADIOPROTECTIVE AGENT;

ADVERSE EFFECTS; AGED; HUMAN; INFLAMMATION; LUNG; LUNG ALVEOLUS CELL; LUNG INJURY; PATHOPHYSIOLOGY; PULMONARY FIBROSIS; RADIATION PNEUMONITIS; RADIATION RESPONSE; THORAX RADIOGRAPHY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; INFLAMMATION; LUNG; LUNG INJURY; PENTOXIFYLLINE; PNEUMOCYTES; PREDNISOLONE; PULMONARY FIBROSIS; RADIATION PNEUMONITIS; RADIATION-PROTECTIVE AGENTS; RADIOGRAPHY, THORACIC;

EID: 84928623842     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.7.2613     Document Type: Short Survey

References (34)

1. Albert RK, Connett J, Bailey WC, et al (2011). Azithromycin for prevention of exacerbations of COPD. N Engl J Med, 365, 689-98.
2. Anscher MS, Kong FM, Andrews K, et al (1998). Plasma TGF B1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys, 41, 1029-35.
3. Bradley J, Movsas B (2006). Radiation pneumonitis and esophagitis in thoracic irradiation. In: Small W, Woloschak GE, eds. Radiation Toxicity: a Practical Guide. New York, NY: Springer Science+Media Business, Inc, 43-52.
4. Castillo R, Pham N, Ansari S, et al (2014). Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer. Radiat Oncol, 9, 74.
5. Chen Y, Ollivier H, Williams J, et al (2005). IL 1a and IL 6 application to the predictive diagnosis of radiation pneumonitis. Int J Radiat Oncol Biol Phys, 62, 260-6.
6. Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6.
7. Faria S, Lisbona R, Stem J, et al (2007). Is post-treatment FDG-PET/CT useful in differentiating tumor from fibrosis after curative radiation therapy (RT) alone for lung cancer? Int J Radiat Oncol Biol Phys, 69, 519-20.
8. Fleckenstein K, Zgonjanin L, Chen L (2007). Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys, 68, 196-204.
9. Gao F, Fish BL, Moulder JE, et al (2013). Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35 days after whole-thorax irradiation. Radiat Res, 180, 546-52.
10. Ghafoori P, Marks LB, Vujaskovic Z, Kelsey CR (2008). Radiation-induced lung injury. Assessment Manage Prev Oncol, 22, 37-47.
11. Hideomi Yamashita, Wataru Takahashi; Akihiro Haga; Keichi Nakagawa (2014). Radiation pneumonitis after SBRT for lung cancers. W J radiology, 6, 708-15.
12. Hoover DA, Reid RH, Wong E, et al (2014). SPECT-based functional lung imaging for the prediction of radiation pneumonitis: a clinical and dosimetric correlation. J Med Imaging Radiat Oncol, 58, 214-22.
13. Ivan R Vogelius, Soren M Bentzen (2012). A literature based Meta analyses of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol, 51, 975-83.
14. Juweid ME, Stroobants S, Hoekstra OS, et al (2007). Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol, 25, 571-8.
15. Kouloulias V, Zygogianni A, Efstathopoulos E, et al (2013). Suggestion for a new grading scale for radiation pneumonitis based on radiological findings of computerized tomography: Correlation with clinical and radiotherapeutic parameters in lung cancer patients. Asian Pac J Cancer Prev, 14, 2717-22.
16. Lind JS, Senan S, Smit EF (2012). Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer. J Clin Oncol, 30, 104-8.
17. McDonald S, Rubin P, Phillips TL, et al (1995). Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys, 31, 1187.
18. Medhora M, Gao F, Jacobs ER, Moulder JE (2012). Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology, 17, 66-71.
19. Molteni A, Moulder JE, Cohen EF, et al (2000). Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol, 76, 523-32.
20. Osterreicher J, Mokry J, Navrátil L, et al (2001). The alveolar septal thickness and type II pneumocytes number in irradiated lungs, time expression and the effect of pentoxifylline. Acta Medica, 44, 15-9.
21. Palma DA, Senan S, Tsujino K, et al (2013). Predicting radiation pneumonitis after chemoradiotherapy of lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys, 85, 444-50.
22. Rancati T, Ceresoli GL, Gagliardi G, et al (2003). Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol, 67, 275.
23. Rube CE, Wilfert F, Palm J, et al (2004). Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung. StrahlentherOnkol, 180, 442-8.
24. Taghian AG, Assaad SI, Niemierko A, et al (2001). Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst, 93, 1806.
25. Thind K, Chen A, Friesen-Waldner L, et al (2012). Detection of radiation-induced lung injury using hyperpolarized (13) C magnetic resonance spectroscopy and imaging. Magn Reson Med, 70, 601-9.
26. Trott KR, Herrmann T, Kasper M, et al (2004). Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys, 58, 463-469.
27. Tsujino K, Hirota S, Endo M, et al (2003). Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys, 55, 110-5.
28. Tsujisaki M, Imai K, Irata H, et al (1991). Detection of circulating ICAM1 in malignant diseases. Clin Exp Immunology, 81, 3-8.
29. Urbanic JJ, Lally B, Blackstock AW (2009). The best-laid plans often go awry.". J Thorac Oncol, 4, 783.
30. Vujaskovic Z, Anscher MS, Feng QF. et al (2001). Radiation-induced hypoxia may peRILIetuate late normal tissue injury. Int J RadiatOncolBiolPhys, 50, 851-5.
31. Wang J, Cao J, Yuan S, Ji W (2013). Poor baseline pulmonary function may not increase the risk of radiation induced lung toxicity. Int J Radiat Oncol Biol Phys, 85, 798-804.
32. Xiong H, Liao Z, Liu Z, et al (2013). ATM polymorphisms predict severe radiation pneumonitis in ptients with non-small cell carcinoma lung treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys, 85, 1066-73.
33. Zhao W, Robbins ME (2009). Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: Therapeutic implications. Curr Med Chem, 16, 130-43.
34. Zhao L, Sheldon K, Chen M, Yin MS (2008) predictive role of plasma TGF B1 during radiation therapy for radiation lung toxicity deserves further study in patients with NSCLC. Lung Cancer, 59, 232-9.